跳至主要内容
临床试验/JPRN-UMIN000015427
JPRN-UMIN000015427招募中未知

Prognostic Assessment for Patients Notified as Dual Obstructive Atherosclerosis Requiring Angioplasties - PANDORA Registry

Department of Cardiology, Fujita Health University0 个研究点目标入组 300 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

The prevalence of TVD/LMT and HRP determined by coronary CTA is higher in patients needing CAS/CEA than in those without. Management of systemic atherosclerosis is required in the perioperative period of CAS/CEA.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Those who underwent coronary artery bypass grafting Those who have severe chronic lidney disease (estimated glomerular filtration rate <30mL/min/1.73m2) Those who have iodinated contrast medium allergy Those who are not willing to participate in the study

研究者

发起方
Department of Cardiology, Fujita Health University

相似试验

Prognostic Assessment for Patients Notified as Dual... | 临床试验